Biointelect

💡 Ready to take your idea to the next level but wondering how to fund it? 💡 Register now for the Biointelect Venturer Program! arcs.com.au/events/venture… The 2023 courses will be held across 5 states, with the first in Adelaide on Thursday 16th February.

NOVAVAX APPROVED: Nuvaxovid is the first protein-based COVID-19 vaccine registered for use as a booster in Australia. Novavax, Inc today announced the TGA has granted provisional registration of the Nuvaxovid COVID-19 vaccine as a booster in individuals aged 18 and over. #9News

Novavax will be giving six different presentations showcasing our vaccine data at Australia's Communicable Diseases & Immunisation Conference, #CDIC2022. Learn more: bit.ly/3Hug1IZ

This next episode we discuss with Jennifer Herz from #Biointelect how she and Karl Herz from #Biocelect established their #relationship with @novavax leading to Biocelect being their sponsor for the #covid19vaccine in Australia and New Zealand

Congratulations to the Novavax and Biocelect team for this milestone ir.novavax.com/2021-10-29-Nov…

@normanswan @englishheadline @normanswan Novavax doses for Australia will be made from the supply network outside the US, so should be no impact; Each regulator will be making their own assessment of the Novavax vaccine – including the MHRA, EMA and TGA, thanks for your coverage.

Another hiccup in our vaccine supply. Even more reliant on Pfizer. Novavax Says U.S. Will Pause Funding for Production of Its Vaccine englishheadline.com/novavax-says-u… via @Englishheadline - News Today's News Headlines Breaking News

@ARCSAustralia Thank-you @ARCSAustralia and @biomelbourne network for a great event. Congratulations to all the winners

Congratulations Jenny Herz! Well deserved award for an amazing woman, frequent contributor to the sector and ARCS partner.

Come and meet the ⁦@BiointelectInfo⁩ team at booth 33 at the ⁦@ARCSAustralia⁩ 2021 conference #arcsaus #commercialisation

Can’t wait to see you all today! #ARCSAus #ARCS2021

Go @novavax and @nhs !

Congratulations @novavax

Great panel discussion just now at @MTPConnect_AUS launch of @AAMRNet_ . @BiointelectInfo can support your business case, project management, grant writing as well as market access strategy for Antimicrobials

Great news for @Novavax and for Australia to have this phase 1 trial starting in Melbourne abc supported by @TheNucleusNet and @360biolabs

@biomelb Thanks for the invite @biomelb very professionally organised and great group of workshop participants

Congratulations to Biocelect for the launch of their first product !

1st Shipment of Kodatef (tafenoquine succinate) for Malaria Prophylaxis arrives in Sydney linkedin.com/pulse/1st-ship…

lnkd.in/eBXsqSK lnkd.in/eFj8uWY

RT @MTPConnect_AUS: In this week of #ICYMI - we feature activities from our CEO @DrDanGrant, our GM Stakeholder Engagement Dr Alfredo Marti…

Encouraging #cancer patients and patient organisations to have their say about funding of new treatments - please complete our survey if you are interested lnkd.in/frTuhfE

@BiointelectInfo at #AusBio18